Kantonsspital St.Gallen

Polymorphisms of SOCS-1 are associated with rapid HIV progression rate

Martin Hersberger, Erika Schlaepfer, Marco Buehler, Pierre-Yves Bochud, Pietro Vernazza, Jacqueline Marti-Jaun, Johannes Nemeth, Marcel Zwahlen, Kurt Schmidlin & Roberto F Speck


Immune activation, among other driven by IFN-α and -γ activation is a main feature of progressive HIV infection. Suppressor of cytokine signaling (SOCS) 1 and 3 are negative feedback regulators of the IFN-α and -γ axis. Here, we analyzed the role of 9 single nucleotide polymorphisms (SNPs) within SOCS-1 and 3 genes for their association with HIV progression rate in a cohort of 318 rapid vs 376 slow progressors from the Swiss HIV Cohort Study.

AND METHODS: We analyzed 9 SNPs, which we have identified in Swiss blood donors, in a cohort of HIV-infected patients (n=1144), which have been categorized according to the decline in CD4+ T-cell counts. In all the conducted analyses, we focused on the comparison between rapid and slow progressors with regard to SNPs in SOCS1 and -3 and with regards to haplotypes using multivariate logistic regression models.

Three SOCS-1 SNPs (rs193779; rs33989964; and rs4780355) are associated with a risk reduction for rapid progression. Two of these SNPs, rs33989964 and rs4780355, are in strong linkage disequilibrium forming a frequent haplotype. Homozygous carriers of this haplotype are also associated with a risk reduction for rapid progression. In contrast, the minor TT genotype of rs33977706 is associated with twice the risk for rapid progression. No associations have been observed for the four SOCS-3 SNPs or the major SOCS-3 haplotypes.

Our data suggest that SNPS in SOCS-1 are associated with HIV disease progression and speak in favor that immune activation is causal for the progressive immunodeficiency.
citation Hersberger M, Schlaepfer E, Buehler M, Bochud P Y, Vernazza P, Marti-Jaun J, Nemeth J, Zwahlen M, Schmidlin K, Speck R F. Polymorphisms of SOCS-1 are associated with rapid HIV progression rate. J Acquir Immune Defic Syndr 2020;.
type journal paper/review (English)
date of publishing 21-02-2020
journal title J Acquir Immune Defic Syndr
ISSN electronic 1944-7884
PubMed 32097250
DOI 10.1097/QAI.0000000000002319